Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.
Assessment of in vitro susceptibility testing of Helicobacter pylori is difficult because of the fastidious, slowly growing nature of this microorganism. The high rate of relapse observed clinically and a possible subpopulation of cells that are not actively replicating suggest the potential need for bactericidal therapy in order to eradicate H. pylori. We used modified time-kill kinetic methodology in order to evaluate the bactericidal activities of ampicillin and bismuth, alone and in combination, against three strains of H. pylori in both a stationary (slow) growth phase and a logarithmic (rapid) growth phase. We found that ampicillin produced a decrease in CFU per milliliter (2 to 4 log10 units) for three strains of H. pylori when tested in logarithmic growth phases but was less inhibitory (< 1-log10-unit decrease in CFU per milliliter) when tested in a stationary growth phase. In contrast, bismuth, when tested in a logarithmic growth phase, produced little inhibitory effect, as the CFU for all strains tested increased above the inoculum. However, when tested in a stationary growth phase, bismuth produced a decrease in CFU per milliliter of < 1 to > 3 log10 units). The activities of these two agents when combined mimicked the activity of the most active drug alone for that growth phase. We conclude that the clinical use of ampicillin combined with bismuth has been more effective than that of either agent used alone because ampicillin targets replicating cells, whereas bismuth targets cells that are not actively replicating.
Coudron
P E
PE
Department of Pathology and Laboratory Medicine, McGuire Veterans Affairs Medical Center, Richmond, Virginia 23249-0001.
Stratton
C W
CW
D000667:Ampicillin / Q000494:pharmacology*; D001729:Bismuth / Q000494:pharmacology*; D004338:Drug Combinations; D004341:Drug Evaluation; D016480:Helicobacter pylori / Q000187:drug effects* / Q000254:growth & development; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D013997:Time Factors
D004338:Drug Combinations; D000667:Ampicillin; D001729:Bismuth